| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.00086 | 1 |